- Interferon alpha in treatment of CML patients - resultsPublication without faculty affiliation
- Recent changes in treatment of CML2006 | Publication without faculty affiliation
- Gene expression profiling in CML patients using Atlas Plastic 8K Microarrays2006 | Faculty of Science
- Imatinib (glivec) in the Treatment of patients with CML in accelerated phase and Ph+ ALL2003 | First Faculty of Medicine
- Camelia-international registry of CML patients2006 | Publication without faculty affiliation
- CML - update of experiences and studies2010 | First Faculty of Medicine
- BCR-ABL mutation analysis allows to provide "tailors therapy" for CML patients resistant to imatinib2010 | Faculty of Medicine in Hradec Králové
- Report of University Hospital Hradec Králové to the clinical trial protocol No: CAMN107AIC05Publication without faculty affiliation
- Dasatinib in imatinib-resistant or -intolerant CML patients: data from the clinical practice of 6 hematological centers in the Czech Republic2010 | Faculty of Physical Education and Sport, Faculty of Medicine in Hradec Králové
- Dasatinib in imatinib-resistant or -intolerant CML patients: data from the clinical practice of 6 hematological centers in the Czech Republic2010 | First Faculty of Medicine
- Comments to the study Dasatinib 140 mg once daily vs dasatinib 70 mg bid in patients with CML in accelerated phase +12009 | Publication without faculty affiliation
- Imatinib resistance in CML treatment +12008 | Publication without faculty affiliation
- Imatinib (glivec) in the Treatment of patients with CML in accelerated phase and Ph+ ALL2003 | Faculty of Medicine in Hradec Králové
- Current view to haemopoietic cells transplantation in CML, results in Czech Republic2006 | Faculty of Medicine in Hradec Králové
- Possible discontinuation of treatment by tyrosine kinase inhibitors in patients with chronic myeloid leukemia and concept of treatment-free remission2017 | Publication without faculty affiliation
- Results of the CML treatment in years 1990-1998 - the retrospective assessment of 4 centres database1999 | Faculty of Medicine in Hradec Králové
- Chronic myeloid leukemia. Recommendations for diagnosis, monitoring and treatment of CML in adults, updated version 20112011 | Faculty of Medicine in Hradec Králové
- Sledování kinetiky mutací v BCR-ABL u pacientů s CML léčených inhibitory tyrozin kinázPublication without faculty affiliation
- Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendations2023 | Second Faculty of Medicine
- Response to treatment in women with chronic myeloid leukemia during pregnancy and after delivery2009 | First Faculty of Medicine
- Current treatment of chronic myeloid leukemia - tyrosinkinas inhibitors.2012 | First Faculty of Medicine
- Simple competitive two-step RT-PCR assay to monitor minimal residual disease in CML patients after bone marrow transplantation1998 | Second Faculty of Medicine
- Where does treatment of chronic myeloid leukemia target tyrosine kinase inhibitors?2018 | First Faculty of Medicine
- Diagnostic and treatment recommendations in chronic myeloid leukemia adult patients +1Publication without faculty affiliation
- Impact of age on the clinical response of patients with CML treated with imatinib2015 | Faculty of Medicine in Hradec Králové
- Gene expression profiles of two accelerations in a CML patient2006 | Central Library of Charles University
- Hsp90-a potential prognostic marker in CML2013 | Faculty of Science